Advertisement

Fatigue

  • Carmen P. Escalante
  • Ellen F. Manzullo
Chapter
Part of the MD Anderson Cancer Care Series book series (MDCCS)

Abstract

Fatigue is a common symptom experienced by cancer survivors. It is important for the clinician to question the patient about the presence of this symptom because patients are often hesitant to mention it. In addition, cancer-related fatigue (CRF) commonly clusters with other symptoms, such as sleep disturbance, pain, depression, and anxiety. Patients with moderate to severe CRF should undergo a comprehensive evaluation that includes a history, physical examination, laboratory evaluation, and an assessment of their fatigue and possible associated symptoms. Nonpharmacologic interventions for the treatment of CRF include psychosocial interventions, activity enhancement, dietary management, and sleep management; pharmacologic interventions include agents such as stimulants. Further research is needed to elucidate the actual pathophysiology of CRF and better tailor treatment strategies.

Keywords

Obstructive Sleep Apnea Cancer Survivor National Comprehensive Cancer Network Psychosocial Intervention Activity Enhancement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Readings

  1. Auret KA, Schug SA, Bremner AP, Bulsara M. A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. J Pain Symptom Manage 2009;37(4):613–621.PubMedCrossRefGoogle Scholar
  2. Blackhall L, Petroni G, Shu J, Baum L, Farace E. A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med 2009;12(5):433–439.PubMedCrossRefGoogle Scholar
  3. Bruera E, El Osta B, Valero V, et al. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2007;25:3475–3481.PubMedCrossRefGoogle Scholar
  4. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 1985;69(7–8):751–754.PubMedGoogle Scholar
  5. Bruera E, Valero V, Driver L, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24(13):2073–2078.PubMedCrossRefGoogle Scholar
  6. Cruciani RA, Dvorkin E, Homel P, et al. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study. J Pain Symptom Manage 2009;37(4):622–631.PubMedCrossRefGoogle Scholar
  7. Escalante CP, Kallen MA, Valdres RU, et al. Outcomes of a cancer-related fatigue clinic in a comprehensive cancer center. J Pain Symptom Manage 2010;39(4):691–701.PubMedCrossRefGoogle Scholar
  8. Gabrilove JL, Perez E, Tomita DK, Rossi G, Cleeland CS. Assessing symptom burden using the MD Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 micrograms every 2 weeks. Cancer 2007;110(7):1629–1640.PubMedCrossRefGoogle Scholar
  9. Jean-Pierre P, Morrow GR, Roscoe JA, et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer 2010;116(14):3513–3520.PubMedCrossRefPubMedCentralGoogle Scholar
  10. Lyman GH, Glaspy J. Are there clinical benefits with early erythropoietic intervention for chemotherapy-induced anemia? A systematic review. Cancer 2006;106(1):223–233.PubMedCrossRefGoogle Scholar
  11. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999;85(5):1186–1196.PubMedCrossRefGoogle Scholar
  12. Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 2000;14(11A):151–161.Google Scholar
  13. Mock V, Atkinson A, Barsevick A, et al. Cancer-related fatigue. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2007;5(10):1054–1078.PubMedGoogle Scholar
  14. Molassiotis A, Sylt P, Diggins H. The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med 2007;15(4):228–237.PubMedCrossRefGoogle Scholar
  15. Morrow GR, Jean-Pierre P, Roscoe JA, et al. A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: a URCC CCOP study (abstract). J Clin Oncol 2008;504s.Google Scholar
  16. Moss E, Simpson JS, Pelletier G, et al. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psychooncology 2006;15:259–267.PubMedCrossRefGoogle Scholar
  17. Rabkin J, McElhiney MC, Rabkin R. Treatment of HIV-related fatigue with armodafinil: a placebo-controlled randomized trial. Psychosomatics 2011;52(4):328–336.PubMedCrossRefPubMedCentralGoogle Scholar
  18. Sood A, Barton DL, Bauer BA, Loprinzi CL. A critical review of complementary therapies for cancer-related fatigue. Integr Cancer Ther 2007;6(1):8–13.PubMedCrossRefGoogle Scholar
  19. de Souza F, Bensi C, Trufelli DC, et al. Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial. Am J Clin Oncol 2007;30:432–436.CrossRefGoogle Scholar
  20. Spathis A, Dhillan R., Booden D, Forbes K, Vrotsou K, Fife K. Modafinil for the treatment of fatigue in lung cancer: a pilot study. Palliat Med 2009;23(4):325–331.PubMedCrossRefGoogle Scholar
  21. Vickers AJ, Straus DJ, Fearon B, Cassileth BR. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol 2004;22(9):1731–1735.PubMedCrossRefGoogle Scholar

Copyright information

© The University of Texas M. D. Anderson Cancer Center 2015

Authors and Affiliations

  • Carmen P. Escalante
    • 1
  • Ellen F. Manzullo
    • 1
  1. 1.Department of General Internal MedicineThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations